Last update 31 Oct 2026

RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)

Overview

Basic Info

Drug Type
Prophylactic vaccine, mRNA vaccine
Synonyms-
Target
SARS-CoV-2 S protein
Action
inhibitors
Mechanism
SARS-CoV-2 S protein inhibitors(SARS-CoV-2 S protein inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication-
Originator Organization
Agna Biopharmaceutical Co., Ltd.Guangzhou Medical UniversityGuangzhou Medical UniversityGuangzhou Ribobio Co., Ltd.Guangzhou Ribobio Co., Ltd.
Active Organization
Guangzhou Ribobio Co., Ltd.Guangzhou Ribobio Co., Ltd.Guangzhou Medical UniversityGuangzhou Medical University
Inactive Organization
Agna Biopharmaceutical Co., Ltd.
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
NCT05903118
/ CompletedPhase 1/2
A Phase I/II, Randomized, Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (RBMRNA-176) in Healthy Adults Aged 18 Years and Older
100 Clinical Results associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data
100 Translational Medicine associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data
100 Patents (Medical) associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data
100 Deals associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
China
Agna Biopharmaceutical Co., Ltd.
08 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free